Your browser doesn't support javascript.
loading
Concentration-QTc Modeling of Ozanimod's Major Active Metabolites in Adult Healthy Subjects.
Briggs, Emily; Chapel, Sunny; Zhang, Peijin; Palmisano, Maria; Tran, Jonathan Q.
Affiliation
  • Briggs E; Ann Arbor Pharmacometrics Group, Ann Arbor, Michigan, USA.
  • Chapel S; Ann Arbor Pharmacometrics Group, Ann Arbor, Michigan, USA.
  • Zhang P; Clinical Pharmacology and Pharmacometrics and Research and Early Development, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Palmisano M; Clinical Pharmacology and Pharmacometrics and Research and Early Development, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Tran JQ; Clinical Pharmacology and Pharmacometrics and Research and Early Development, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
CPT Pharmacometrics Syst Pharmacol ; 10(2): 119-126, 2021 02.
Article in En | MEDLINE | ID: mdl-33314790
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxadiazoles / Multiple Sclerosis, Relapsing-Remitting / Sphingosine 1 Phosphate Receptor Modulators / Sphingosine-1-Phosphate Receptors / Indans Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxadiazoles / Multiple Sclerosis, Relapsing-Remitting / Sphingosine 1 Phosphate Receptor Modulators / Sphingosine-1-Phosphate Receptors / Indans Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2021 Document type: Article Affiliation country: